MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
Cristina Pellegrini(University of L'Aquila), Francesco Sera(University of Florence), Míriam Potrony(Hospital Clínic de Barcelona), José C. García‐Borrón(Instituto Murciano de Investigación Biosanitaria), Patrick Maisonneuve(European Institute of Oncology), Daniela Massi(University of Florence), Anne Ε. Cust(The University of Sydney), Sara Gandini(European Institute of Oncology), Emilia Migliano(San Gallicano Hospital), Gloría Ribas(Spanish National Cancer Research Centre), Paola Ghiorzo(Ospedale Policlinico San Martino), Florence Démenais(Inserm), Roberto Zanetti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Nancy E. Thomas(University of North Carolina at Chapel Hill), Chiara Menin(Istituto Oncologico Veneto), Brigitte Bressac–de Paillerets(Institut Gustave Roussy), Gabriella Guida(University of Bari Aldo Moro), S. Brugnara(Ospedale Santa Chiara), Richard P. Gallagher(BC Cancer Agency), Ignazio Stanganelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marianne Berwick(Memorial Sloan Kettering Cancer Center), Terence Dwyer(The University of Melbourne), Eduardo Nagore(Valencia Catholic University Saint Vincent Martyr), Pietro Quaglino(Department of Medical Sciences), Hongmei Nan(Richard M. Fairbanks Foundation), Antonella Romanini(Ospedale Santa Chiara), Fezal Özdemir(Ege University), Federica Baldini(European Institute of Oncology), Stephen B. Gruber(City Of Hope National Medical Center), Veronica Höiom(Karolinska Institutet), Julian Little(University of Ottawa), Lidija Kandolf Sekulović(Military Medical Academy), Hoda Anton‐Culver(University of California, Irvine), Fabio Facchetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Colin B. Begg(Memorial Sloan Kettering Cancer Center), Susana Puig(Instituto de Salud Carlos III), Maria Antonietta Pizzichetta(University of Trieste), Monica Rodolfo(Fondazione IRCCS Istituto Nazionale dei Tumori), Peter A. Kanetsky(Cancer Research And Biostatistics), Francesca Botta(European Institute of Oncology), Julia Newton‐Bishop(University of Leeds), Fabrizio Ayala(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ricardo Fernández‐de‐Misa(Hospital Universitario Nuestra Señora de Candelaria), Marie‐Françoise Avril(Délégation Paris 7), Ausilia Maria Manganoni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alexandros Stratigos(National and Kapodistrian University of Athens), Claudia Martorelli(University of L'Aquila), Emanuela Passoni(University of Milan), Maria Teresa Landi(National Cancer Institute), Loraine D. Marrett(Piedmont Reference Center for Epidemiology and Cancer Prevention)
Cited by 20
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k